688799 华纳药厂
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.30512.3919.31812.73011.886
总资产报酬率 ROA (%)0.8548.6447.08810.0979.605
投入资产回报率 ROIC (%)0.99110.2698.52012.04411.343

边际利润分析
销售毛利率 (%)57.28260.28561.63064.78567.712
营业利润率 (%)10.22715.98711.44916.54915.163
息税前利润/营业总收入 (%)10.27216.00110.23015.18414.494
净利润/营业总收入 (%)8.28115.1649.82113.47313.413

收益指标分析
经营活动净收益/利润总额(%)96.51059.97996.83596.90293.022
价值变动净收益/利润总额(%)-1.72735.009-11.5431.5594.091
营业外收支净额/利润总额(%)-0.0030.170-0.055-3.147-0.534

偿债能力分析
流动比率 (X)2.8292.8643.4214.0134.234
速动比率 (X)1.8301.9082.4362.9343.083
资产负债率 (%)35.93533.10725.90118.77417.439
带息债务/全部投入资本 (%)22.73317.6646.2772.3762.068
股东权益/带息债务 (%)324.088443.8171,411.6123,980.9374,575.411
股东权益/负债合计 (%)178.283202.054283.082421.701455.722
利息保障倍数 (X)222.349-1,143.054-8.441-17.654-24.640

营运能力分析
应收账款周转天数 (天)53.45145.31441.33439.24738.762
存货周转天数 (天)254.288242.519257.343250.413275.918